Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

0.459
Delayed Data
As of 3:59pm ET
 +0.0542 / +13.39%
Today’s Change
0.31
Today|||52-Week Range
9.22
-90.63%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close0.40
Today’s open0.42
Day’s range0.41 - 0.56
Volume3,451,162
Average volume (3 months)1,014,504
Market cap$16.7M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+54.64%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+82.41%
P/E ratioNM
Price/Sales165.87
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
NVGNNovogen Ltd+0.03+3.63%
CBIOCatalyst Biosciences...+0.28+7.02%
RPRXRepros Therapeutics ...-0.02-3.48%
MBRXMoleculin Biotech In...-0.07-7.87%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$945.5K
Annual profit (last year)-$53.0M
Net profit margin-5,608.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Financial Officer &
Vice President
Richard D. Katz
Corporate headquarters
Durham, North Carolina

Forecasts